Antiphospholipid syndrome: epidemiology and outcomes in the evolving criteria era.
- DOI
- 10.1038/s41584-026-01438-7
- Published
- 2026 Nov
- Container
- Nature reviews. Rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41584-026-01438-7,
title = {Antiphospholipid syndrome: epidemiology and outcomes in the evolving criteria era.},
author = {El Hasbani G and Schreiber K and Rodríguez-Pintó I and Devreese KMJ and Andrade D and Duarte-García A},
year = {2026},
journal = {Nature reviews. Rheumatology},
doi = {10.1038/s41584-026-01438-7},
url = {https://doi.org/10.1038/s41584-026-01438-7}
}RIS
TY - JOUR TI - Antiphospholipid syndrome: epidemiology and outcomes in the evolving criteria era. AU - El Hasbani G AU - Schreiber K AU - Rodríguez-Pintó I AU - Devreese KMJ AU - Andrade D AU - Duarte-García A PY - 2026 JO - Nature reviews. Rheumatology DO - 10.1038/s41584-026-01438-7 UR - https://doi.org/10.1038/s41584-026-01438-7 ER -
APA
G, E. H., K, S., I, R., KMJ, D., D, A., & A, D. (2026). Antiphospholipid syndrome: epidemiology and outcomes in the evolving criteria era.. Nature reviews. Rheumatology. https://doi.org/10.1038/s41584-026-01438-7
Source records
- pubmed · retrieved 2026-11-10T13:03:31.730Z